The civic record
Read. Follow. Verify.House committee advances bill to expedite Medicare coverage for breakthrough medical devices
Last action · September 17, 2025: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
The Ensuring Patient Access to Critical Breakthrough Products Act requires the Centers for Medicare & Medicaid Services (CMS) to establish a streamlined pathway for Medicare coverage of medical devices designated as 'breakthrough' by the FDA. This measure aims to reduce the time between FDA approval and Medicare payment for new, innovative medical technologies.
This bill directly impacts patients with serious or life-threatening conditions by potentially accelerating their access to cutting-edge medical devices that are currently delayed by separate Medicare coverage review processes.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Medicare beneficiaries
Patients may gain faster access to new medical technologies that receive breakthrough designation.
medical device manufacturers
Companies producing breakthrough devices may see a reduction in the time required to secure Medicare reimbursement.
Centers for Medicare & Medicaid Services
The agency is required to establish and manage the new expedited coverage pathway mandated by the bill.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What is a 'breakthrough' device?
How does this change current Medicare rules?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
RS GROUP CONSULTING LLC
on behalf of INSIGHTEC, INC.
RS GROUP CONSULTING LLC
on behalf of INSIGHTEC, INC.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Streamlining Coverage
The bill represents a shift toward automating Medicare coverage for products already vetted by the FDA as 'breakthrough' technologies.
Connected Entities
Sources
www.congress.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools